NPI: 1821115023 · WAUSAU, WI 54401 · Clinical Medical Laboratory · NPI assigned 03/23/2007
Authorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
| Authorized Official | YANG, JERRY (SVP & CHIEF FINANCIAL OFFICER) |
| Parent Organization | ASPIRUS WAUSAU HOSPITAL, INC |
| NPI Enumeration Date | 03/23/2007 |
Other providers sharing the same authorized official: YANG, JERRY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,356 | $329K |
| 2019 | 40,501 | $593K |
| 2020 | 48,920 | $1.07M |
| 2021 | 80,094 | $1.85M |
| 2022 | 82,501 | $1.63M |
| 2023 | 57,749 | $780K |
| 2024 | 44,131 | $671K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 28,143 | 24,176 | $2.08M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3,509 | 2,767 | $404K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10,496 | 9,417 | $304K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10,380 | 9,308 | $300K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 20,966 | 17,767 | $273K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 11,618 | 10,355 | $266K |
| 84443 | Thyroid stimulating hormone (TSH) | 16,825 | 14,995 | $220K |
| 87070 | 27,472 | 25,437 | $217K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,466 | 1,333 | $175K |
| 81514 | 1,021 | 862 | $137K | |
| 80061 | Lipid panel | 13,730 | 12,511 | $137K |
| 87653 | 4,255 | 3,934 | $126K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 621 | 521 | $113K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,046 | 5,196 | $105K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,920 | 14,249 | $103K |
| 87505 | 1,009 | 905 | $103K | |
| 80081 | 5,607 | 1,212 | $83K | |
| 80053 | Comprehensive metabolic panel | 9,075 | 7,858 | $76K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,471 | 1,134 | $75K |
| 86803 | 6,573 | 5,738 | $74K | |
| 87088 | 11,317 | 10,084 | $71K | |
| 84403 | 2,832 | 2,501 | $61K | |
| 82607 | 4,385 | 3,885 | $54K | |
| 87077 | 7,602 | 6,503 | $52K | |
| 80074 | 1,549 | 1,309 | $51K | |
| 84702 | 4,296 | 3,040 | $49K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8,749 | 7,376 | $48K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1,080 | 931 | $41K |
| 87186 | 5,696 | 5,036 | $41K | |
| 87660 | 2,477 | 2,191 | $39K | |
| 87480 | 2,475 | 2,190 | $39K | |
| 86618 | 2,859 | 2,364 | $38K | |
| 82746 | 3,137 | 2,763 | $37K | |
| 86480 | 788 | 663 | $36K | |
| 87510 | 2,475 | 2,190 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,370 | 4,606 | $35K |
| 82728 | 3,232 | 2,858 | $35K | |
| 84153 | 2,205 | 1,982 | $34K | |
| 84270 | 1,701 | 1,491 | $30K | |
| 84439 | 4,178 | 3,657 | $30K | |
| 84481 | 2,191 | 1,941 | $29K | |
| 80306 | 2,003 | 1,829 | $29K | |
| 82670 | 1,234 | 1,096 | $28K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,655 | 3,350 | $26K |
| 86762 | 2,895 | 2,443 | $26K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,924 | 984 | $26K |
| 82043 | 5,189 | 4,865 | $25K | |
| 85027 | 5,014 | 4,362 | $25K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 598 | 520 | $24K |
| 83550 | 3,538 | 3,146 | $24K | |
| 87340 | 3,594 | 3,039 | $23K | |
| 80050 | General health panel | 1,269 | 531 | $23K |
| 81001 | 8,638 | 7,581 | $22K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 590 | 345 | $19K |
| 83540 | 3,744 | 3,338 | $19K | |
| 86039 | 2,154 | 1,798 | $19K | |
| 83655 | 2,366 | 2,184 | $17K | |
| 86592 | 5,252 | 4,525 | $16K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 604 | 501 | $16K |
| 83970 | 424 | 369 | $14K | |
| 84146 | 833 | 752 | $13K | |
| 87328 | 1,176 | 1,049 | $13K | |
| 86140 | 3,097 | 2,565 | $13K | |
| 83001 | 806 | 721 | $12K | |
| 86769 | 365 | 330 | $10K | |
| 83735 | 1,930 | 1,586 | $10K | |
| 82784 | 1,591 | 1,007 | $9K | |
| 87329 | 1,144 | 1,017 | $9K | |
| 84144 | 571 | 475 | $9K | |
| 87205 | 2,346 | 2,076 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 86 | 80 | $8K |
| 86364 | 819 | 592 | $8K | |
| 85610 | 2,283 | 1,569 | $7K | |
| 82950 | 1,871 | 1,696 | $7K | |
| 85018 | 3,621 | 3,073 | $7K | |
| 86431 | 1,376 | 1,177 | $6K | |
| 85049 | 1,709 | 1,537 | $6K | |
| 84436 | 1,083 | 951 | $6K | |
| 86706 | 705 | 603 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 139 | 114 | $5K |
| 87338 | 351 | 319 | $4K | |
| 81025 | 554 | 504 | $4K | |
| 83880 | 138 | 124 | $4K | |
| 87807 | 305 | 268 | $4K | |
| 83002 | 240 | 212 | $4K | |
| 85014 | 1,822 | 1,635 | $3K | |
| 86850 | 1,430 | 1,242 | $3K | |
| 82533 | 282 | 199 | $3K | |
| 87075 | 406 | 354 | $3K | |
| 83690 | 474 | 427 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,178 | 1,025 | $3K |
| 87631 | 22 | 19 | $3K | |
| 85652 | 1,161 | 934 | $2K | |
| 87210 | 473 | 443 | $2K | |
| 82570 | 490 | 450 | $2K | |
| 80076 | 293 | 254 | $2K | |
| 85007 | 715 | 569 | $2K | |
| 86376 | 169 | 150 | $2K | |
| 86665 | 196 | 79 | $2K | |
| 87493 | 32 | 28 | $2K | |
| 86787 | 298 | 229 | $1K | |
| 87046 | 510 | 455 | $1K | |
| 84156 | 482 | 404 | $1K | |
| 84460 | 321 | 274 | $1K | |
| 86900 | 1,083 | 924 | $1K | |
| 80197 | 110 | 62 | $1K | |
| 86901 | 1,084 | 924 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 48 | 40 | $1K |
| 88307 | 80 | 56 | $1K | |
| 83718 | 144 | 134 | $1K | |
| 87522 | Neg quan hep c or qual rna | 57 | 50 | $943.34 |
| 86663 | 109 | 80 | $906.84 | |
| 87147 | 213 | 186 | $886.50 | |
| 86664 | 88 | 68 | $876.52 | |
| 83516 | 229 | 157 | $851.09 | |
| 87468 | 40 | 34 | $779.64 | |
| 87484 | 39 | 33 | $736.89 | |
| 87469 | 39 | 33 | $736.89 | |
| 82465 | 189 | 174 | $727.85 | |
| 84165 | 78 | 58 | $727.82 | |
| 86258 | 84 | 37 | $661.37 | |
| 84550 | 196 | 177 | $651.68 | |
| 83993 | 32 | 32 | $612.24 | |
| 86644 | 58 | 44 | $561.79 | |
| 83721 | 77 | 70 | $540.19 | |
| 84450 | 123 | 109 | $505.52 | |
| 85060 | 130 | 105 | $371.79 | |
| 88304 | 25 | 13 | $309.95 | |
| 86645 | 56 | 42 | $300.90 | |
| 88342 | 22 | 13 | $261.99 | |
| 82947 | 83 | 73 | $234.90 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 15 | 13 | $228.48 |
| 82565 | 50 | 36 | $163.84 | |
| 80164 | 12 | 12 | $158.00 | |
| 86696 | 12 | 12 | $156.36 | |
| 80178 | 14 | 13 | $124.32 | |
| 82247 | 40 | 27 | $116.46 | |
| 84703 | 19 | 18 | $113.10 | |
| 86695 | 12 | 12 | $106.56 | |
| 82977 | 13 | 12 | $89.78 | |
| 82150 | 14 | 13 | $78.02 | |
| 83615 | 15 | 13 | $66.56 | |
| 82248 | 19 | 13 | $65.26 | |
| 82040 | 19 | 15 | $64.35 | |
| 81003 | 29 | 28 | $48.15 | |
| 85730 | 15 | 12 | $48.08 | |
| 36415 | Collection of venous blood by venipuncture | 63 | 52 | $18.77 |